Lining Huang | Bioinformatics | Research Excellence Award

Mr. Lining Huang | Bioinformatics | Research Excellence Award

The Second Hospital of Hebei Medical University | China

Dr. Huang is a distinguished researcher and attending physician specializing in perioperative neuroscience, with a Ph.D. in anesthesiology from Hebei Medical University. His career has centered on elucidating the molecular pathways through which blood–brain barrier dysfunction contributes to neurocognitive decline in aging surgical populations. Integrating molecular biology, neuroimaging, immunology, and microbiome science, he has established a multidisciplinary research program that advances understanding of the vascular–immune mechanisms driving perioperative neurocognitive disorders. From anesthesia-induced neurotoxicity in early studies to complex “vascular-immune–microbiome” interactions in recent work, his contributions span preclinical models, translational investigations, and clinical cohort studies. He has served as principal investigator on more than ten major funded projects, including multiple National Natural Science Foundation of China grants, and has earned notable distinctions such as the Hebei Province Science and Technology Progress Award and several first-prize Hebei Medical Science Awards. His commitment to academic scholarship includes translating Miller’s Anesthesia, editing national textbooks, and co-authoring expert consensus guidelines that shape anesthesiology education and practice nationwide. With a portfolio of influential publications and six national patents in airway-management innovations, Dr. Huang continues to advance therapeutic development and scientific knowledge in surgical brain protection and perioperative cognitive health.

Profile : Scopus

Featured Publications

SPP1-mediated crosstalk between macrophages and fibroblasts promotes benign airway stenosis. (2025). Archives of Biochemistry and Biophysics.

Association between preoperative blood–brain barrier permeability and postoperative delirium in older patients undergoing cardiac surgery: a pilot study. (2025). Aging Clinical and Experimental Research.

Central neuropeptides as key modulators of astrocyte function in neurodegenerative and neuropsychiatric disorders. (2025).

Neonatal sevoflurane exposure disrupted fatty acids metabolism, leading to hypomyelination and neurological impairments. (2025). Biomedicine and Pharmacotherapy.

Jia Liang | Neuroscience Data Analysis | Best Researcher Award

Prof. Jia Liang | Neuroscience Data Analysis | Best Researcher Award

Jinzhou Medical University | China

Prof. Jia Liang, Ph.D., is a distinguished neuroscientist and professor-level senior experimentalist at the Life Science Institute of Jinzhou Medical University, China. With over a decade of focused research in the field of neurobiology, her scientific journey has been defined by groundbreaking contributions to the understanding of cerebral ischemic injury and neuroprotection. Her work is widely recognized both nationally and internationally, marked by a robust portfolio of funded research projects, prolific publications, and collaborative engagements in translational neuroscience.

Professional Profile

SCOPUS

Education

Prof. Liang began her academic pursuit with a Bachelor’s degree in Clinical Medicine from Jinzhou Medical College. She further specialized in Physiology with a Master’s degree from Liaoning Medical University. Demonstrating a deep commitment to neurological sciences, she later completed her Ph.D. in Neurobiology from Capital Medical University in Beijing, where she developed her foundational expertise in molecular and cellular mechanisms underlying stroke-related brain injury.

Experience

Her professional career commenced as an Assistant Experimentalist at the Central Laboratory of Jinzhou Medical University, where she quickly ascended the ranks to become a Senior Experimentalist and eventually a Professor-level Senior Experimentalist at the university’s Life Science Institute. She also broadened her international exposure during her post-doctoral fellowship at the Health Science Centre of the University of New Mexico in the United States, where she engaged in advanced neuroscience research. Throughout her tenure, Prof. Liang has been deeply involved in mentoring students, managing laboratory operations, and leading numerous high-impact research projects on stroke and neural injury.

Research Interest

Prof. Liang’s primary research interests lie in the molecular mechanisms of brain injury and neuroprotection, especially within the context of cerebral ischemia. Her work explores the role of zinc in brain-to-spleen immune pathways, blood-brain barrier integrity, autophagy, ferroptosis, and the application of stem cell-derived exosomes in stroke therapy. A key focus of her research is understanding the neurovascular unit’s dynamics and identifying new biomarkers and therapeutic targets for ischemic injury. Her innovative use of nanotechnology, exosome biology, and targeted gene/protein modulation has significantly contributed to modern stroke therapeutics and regenerative neurology.

Award and Funding

Prof. Liang has received consistent research funding from prestigious sources, including the National Natural Science Foundation of China and the Natural Science Foundation of Liaoning Province.  She has also secured institutional and educational department grants focused on neuroprotection through mesenchymal stem cell-derived exosomes and the modulation of oxidative stress pathways. Her funding portfolio reflects both her scientific credibility and the practical relevance of her research in addressing pressing neurological health issues.

Publications

Brain Targeting Bacterial Extracellular Vesicles Enhance Ischemic Stroke Therapy via Efficient ROS Elimination and Suppression of Immune Infiltration
  • Authors: [Names not provided – please insert from source]

  • Journal: ACS Nano

  • Year: 2025

Indoleamine 2,3-dioxygenase-1 Involves in CD8⁺ T Cell Exhaustion in Glioblastoma via Regulating Tryptophan Levels
  • Authors: [Names not provided – please insert from source]

  • Journal: International Immunopharmacology

  • Year: 2024

β-1,4-Galactosyltransferase 1 Protects Against Cerebral Ischemia Injury in Mice by Suppressing Ferroptosis via the TAZ/Nrf2/HO-1 Signaling Pathway
  • Authors: [Names not provided – please insert from source]

  • Journal: CNS Neuroscience and Therapeutics

  • Year: 2024

Conclusion

Prof. Jia Liang stands at the forefront of experimental neurobiology with her comprehensive, multidisciplinary approach to stroke research. Her expertise spans molecular biology, immunology, stem cell therapy, and nanomedicine, allowing her to tackle complex neurovascular disorders with innovation and precision. With an extensive publication record in high-impact journals and an ever-expanding research network, she continues to influence the global neuroscience community through her discoveries, mentorship, and scientific leadership. Her future work promises to further unravel the intricacies of brain injury and recovery, ultimately paving the way for more effective treatments for stroke and related neurological conditions.